Listening to Immunotherapy – Ultrasound and Photoacoustic Imaging Strategies to Guide and Enhance Cancer Treatments
Open Access
- 6 August 2026
- journal article
- review article
- Published by Springer Nature in Molecular Imaging and Biology
- p. 1-32
Abstract
Immunotherapies are transformative strategies in modern oncology, utilizing the body’s own immune system to stimulate and enhance the antitumor immune response. Successful immunotherapies require precise delivery, real-time monitoring of immune reactions, and flexible treatment strategies that can adapt to patient-specific complexities. These conditions underscore the need for noninvasive, longitudinal imaging approaches to understand therapy progress and maximize response towards precision immunotherapies. Photoacoustic (PA) imaging, especially when integrated with ultrasound (US), is a powerful modality that is gaining momentum in the immunoimaging space. PA imaging enables label-free assessment of functional biological parameters using endogenous chromophores, while engineered exogenous contrast agents extend its capabilities for molecular and cellular imaging towards theranostic applications. These advances allow visualization of immune activity, therapeutic distribution, and treatment-induced microenvironmental changes in real-time. In this review, we focus on the integral role of US/PA imaging in guiding, optimizing, and advancing cancer immunotherapy. This review begins by outlining label-free imaging techniques and the use of exogenous contrast agents as theranostic nanoplatforms in cancer immunotherapies. Following this foundation, we explore US/PA imaging in immunotherapies, emphasizing photoimmunotherapy, adoptive cell immunotherapy, immune checkpoint blockade, and focused ultrasound mediated immunomodulation. Additionally, we highlight complementary multimodal imaging approaches that expand the scope of US/PA guided immunotherapy. Finally, we address key translational challenges, emerging innovations, and future directions for translating US/PA into routine clinical practice.Keywords
Funding Information
- UVA Cancer Center
- Brain Institute, University of Virginia
This publication has 280 references indexed in Scilit:
- NIR‐II Photoacoustic Imaging‐Guided Chemo‐Photothermal Therapy Using PA1094T Combined with Anti‐CD47 Antibody: Activating Pyroptosis against Orthotopic GlioblastomaAdvanced Healthcare Materials, 2024
- ICG-Fluorescence Imaging for Margin Assessment During Minimally Invasive Colorectal Liver Metastasis ResectionJAMA Network Open, 2024
- Bioorthogonal Guided Activation of cGAS‐STING by AIE Photosensitizer Nanoparticles for Targeted Tumor Therapy and ImagingAdvanced Materials, 2023
- Activatable NIR‐II Plasmonic Nanotheranostics for Efficient Photoacoustic Imaging and Photothermal Cancer TherapyAdvanced Materials, 2020
- Gold Nanoframeworks with Mesopores for Raman–Photoacoustic Imaging and Photo‐Chemo Tumor Therapy in the Second Near‐Infrared BiowindowAdvanced Functional Materials, 2020
- Assessment of Nonradioactive Multispectral Optoacoustic Tomographic Imaging With Conventional Lymphoscintigraphic Imaging for Sentinel Lymph Node Biopsy in MelanomaJAMA Network Open, 2019
- Photoacoustic Imaging: Contrast Agents and Their Biomedical ApplicationsAdvanced Materials, 2018
- A Light‐Triggered Mesenchymal Stem Cell Delivery System for Photoacoustic Imaging and Chemo‐Photothermal Therapy of Triple Negative Breast CancerAdvanced Science, 2018
- Nanoparticles of Chlorin Dimer with Enhanced Absorbance for Photoacoustic Imaging and PhototherapyAdvanced Functional Materials, 2018
- Semiconducting Polymer Nanoparticles for Centimeters‐Deep Photoacoustic Imaging in the Second Near‐Infrared WindowAdvanced Materials, 2017